Drug device configured for wireless communication

An ingestible drug delivery device, formed by a device manufacturer, and configured for wireless communication, said drug delivery device comprising:

• a capsule body comprising:
• a sensor for sensing at least one biologic condition within a patient, said sensor comprising at least one binding element that is configured to bind an analyte present in the patient for detecting the at least one biologic condition;
• a bioactive substance module comprising a container for holding a volume and/or quantity of bioactive substance therein and a microactuator for dispensing said bioactive substance from said container to a location outside of said capsule body;
• an electronics module, coupled to said sensor and said bioactive substance module, said electronics module comprising a processor, a transponder and a memory, said memory configured for storing data related to a unique device ID and to a patient identification and configured for storing respective flags set by the device manufacturer and a pharmacist, said sensor providing said processor with a signal indicative of said detected at least one biologic condition;
• a power source coupled to said sensor, said bioactive substance module and said electronics module;
• and
• wherein said processor activates said microactuator to dispense said bioactive substance only if said processor verifies the following conditions:
• (a) a first flag is set by the device manufacturer;
• (b) a second flag is set by the pharmacist;
• and
• (c) a match exists between said patient identification stored in said memory and a patient identification transmitted from an external patient interface device that communicates with said ingested drug device;
• and
• wherein said processor does not activate said microactuator to dispense said bioactive substance if any one of said conditions (a)-(c) is not verified.